GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,863,991 | -28.7% | 2,338,784 | +3.5% | 0.00% | – |
| Q2 2023 | $12,425,924 | +28.9% | 2,259,259 | +0.7% | 0.00% | – |
| Q1 2023 | $9,643,396 | +10.0% | 2,242,650 | +0.5% | 0.00% | – |
| Q4 2022 | $8,769,791 | -25.6% | 2,231,499 | +0.6% | 0.00% | – |
| Q3 2022 | $11,780,000 | -18.8% | 2,218,522 | +0.4% | 0.00% | – |
| Q2 2022 | $14,500,000 | -44.3% | 2,210,309 | -37.7% | 0.00% | -100.0% |
| Q1 2022 | $26,051,000 | +2.4% | 3,549,177 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $25,449,000 | -71.4% | 3,594,461 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $89,026,000 | +2.6% | 3,551,075 | +10.1% | 0.00% | 0.0% |
| Q2 2021 | $86,761,000 | +3.9% | 3,225,326 | +9.9% | 0.00% | 0.0% |
| Q1 2021 | $83,541,000 | +218.1% | 2,935,382 | +216.8% | 0.00% | +100.0% |
| Q4 2020 | $26,265,000 | +0.2% | 926,446 | +9.2% | 0.00% | 0.0% |
| Q3 2020 | $26,213,000 | +2396.5% | 848,047 | +1596.1% | 0.00% | – |
| Q2 2020 | $1,050,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |